Persistent neuropathological effects 14 years following amyloid-β immunization in Alzheimer’s disease
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Persistent neuropathological effects 14 years following amyloid-β immunization in Alzheimer’s disease
Authors
Keywords
-
Journal
BRAIN
Volume 142, Issue 7, Pages 2113-2126
Publisher
Oxford University Press (OUP)
Online
2019-05-09
DOI
10.1093/brain/awz142
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Downregulated apoptosis and autophagy after anti-Aβ immunotherapy in Alzheimer's disease
- (2018) Claire Paquet et al. BRAIN PATHOLOGY
- Differing associations between Aβ accumulation, hypoperfusion, blood–brain barrier dysfunction and loss of PDGFRB pericyte marker in the precuneus and parietal white matter in Alzheimer's disease
- (2017) J Scott Miners et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Vascular cognitive impairment neuropathology guidelines (VCING): the contribution of cerebrovascular pathology to cognitive impairment
- (2016) Olivia A. Skrobot et al. BRAIN
- The amyloid hypothesis of Alzheimer's disease at 25 years
- (2016) Dennis J Selkoe et al. EMBO Molecular Medicine
- Microglial immunophenotype in dementia with Alzheimer’s pathology
- (2016) Thais Minett et al. Journal of Neuroinflammation
- The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease
- (2016) Jeff Sevigny et al. NATURE
- Effect of active Aβimmunotherapy on neurons in human Alzheimer's disease
- (2015) Claire Paquet et al. JOURNAL OF PATHOLOGY
- Amyloid-β11C-PiB-PET imaging results from 2 randomized bapineuzumab phase 3 AD trials
- (2015) Enchi Liu et al. NEUROLOGY
- Effect of amyloid-β (Aβ) immunization on hyperphosphorylated tau: a potential role for glycogen synthase kinase (GSK)-3β
- (2015) Jay Amin et al. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
- Aβ immunotherapy for Alzheimer’s disease: effects on apoE and cerebral vasculopathy
- (2014) Kenji Sakai et al. ACTA NEUROPATHOLOGICA
- Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
- (2014) Stephen Salloway et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inflammatory components in human Alzheimer’s disease and after active amyloid-β42 immunization
- (2013) Elina Zotova et al. BRAIN
- Tau pathology and neurodegeneration
- (2013) Maria Grazia Spillantini et al. LANCET NEUROLOGY
- Pericyte loss influences Alzheimer-like neurodegeneration in mice
- (2013) Abhay P. Sagare et al. Nature Communications
- National Institute on Aging–Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease
- (2012) Bradley T. Hyman et al. Alzheimers & Dementia
- Amyloid-related imaging abnormalities in patients with Alzheimer's disease treated with bapineuzumab: a retrospective analysis
- (2012) Reisa Sperling et al. LANCET NEUROLOGY
- Colombia at the centre of preclinical AD research
- (2012) The Lancet Neurology LANCET NEUROLOGY
- National Institute on Aging–Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease: a practical approach
- (2011) Thomas J. Montine et al. ACTA NEUROPATHOLOGICA
- Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: Recommendations from the Alzheimer’s Association Research Roundtable Workgroup
- (2011) Reisa A. Sperling et al. Alzheimers & Dementia
- Reduction of aggregated Tau in neuronal processes but not in the cell bodies after Aβ42 immunisation in Alzheimer’s disease
- (2010) Delphine Boche et al. ACTA NEUROPATHOLOGICA
- Neuropathology after active Aβ42 immunotherapy: implications for Alzheimer’s disease pathogenesis
- (2010) Delphine Boche et al. ACTA NEUROPATHOLOGICA
- Beneficial effect of human anti-amyloid-β active immunization on neurite morphology and tau pathology
- (2010) Alberto Serrano-Pozo et al. BRAIN
- 11C-PiB PET assessment of change in fibrillar amyloid-β load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study
- (2010) Juha O Rinne et al. LANCET NEUROLOGY
- The biochemical aftermath of anti-amyloid immunotherapy
- (2010) Chera L Maarouf et al. Molecular Neurodegeneration
- Microglial alterations in human Alzheimer's disease following Aβ42 immunization
- (2010) E. Zotova et al. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
- Long-Term Follow-Up of Patients Immunized with AN1792: Reduced Functional Decline in Antibody Responders
- (2009) Bruno Vellas et al. Current Alzheimer Research
- Transmission and spreading of tauopathy in transgenic mouse brain
- (2009) Florence Clavaguera et al. NATURE CELL BIOLOGY
- Consequence of Aβ immunization on the vasculature of human Alzheimer's disease brain
- (2008) D. Boche et al. BRAIN
- Immunotherapy Reduces Vascular Amyloid- in PDAPP Mice
- (2008) S. Schroeter et al. JOURNAL OF NEUROSCIENCE
- Long-term effects of Aβ42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial
- (2008) Clive Holmes et al. LANCET
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now